This invention relates to novel 2,3-diamino-quinazolinone derivatives having medical utility, to use of the 2,3-diamino-quinazolinone derivatives of the invention for the manufacture of a medicament, to pharmaceutical compositions comprising the 2,3-diamino-quinazolinone derivatives of the invention, and to methods of treating a disorder, disease or a condition of a subject, which disorder, disease or condition is responsive to activation of Kv7 channels.
本发明涉及具有医疗用途的新型 2,3-二
氨基
喹唑啉酮衍
生物,涉及使用本发明的 2,3-二
氨基
喹唑啉酮衍
生物制造药物,涉及包含本发明的 2,3-二
氨基
喹唑啉酮衍
生物的药物组合物,还涉及治疗受试者的紊乱、疾病或病症的方法,该紊乱、疾病或病症对 Kv7 通道的激活有反应。